NewsBenzinga报告称,强生公司报告显示,在 ICOTYDE 治疗中,57% 符合条件且伴有皮肤受累的银屑病关节炎患者达到皮肤清除或几乎清除,而安慰剂组为 14%;同时,第 16 周时 ACR20 应答率为 58% 报告称,强生公司报告显示,在 ICOTYDE 治疗中,57% 符合条件且伴有皮肤受累的银屑病关节炎患者达到皮肤清除或几乎清除,而安慰剂组为 14%;同时,第 16 周时 ACR20 应答率为 58% Benzinga 2026.11.09 08:39 (GMT+0) Open on Benzinga Other news AI models can be tricked into identifying civilians as military targets by telling them it’s a game Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here. 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT